Intrinsiqs

Is Corcept Therapeutics Incorporated overvalued?

Corcept Therapeutics Incorporated (CORT) — key valuation metrics and fundamentals.

No verdict
Price
$110.51
Fair value
—
Current P/E
—
Normal P/E
22.3
Market cap
$11.95B
Dividend yield
0.0%
Return on equity
8.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CORT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.